Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP

Last updated on 2025-04-08 History
Report ID 186632
Drug Identification Number 02486628
Brand name SODIUM BICARBONATE INJECTION, USP
Common or Proper name SODIUM BICARBONATE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 42MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 5 mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-03-08
Estimated end date Unknown
Actual end date 2024-09-10
Shortage status Resolved
Updated date 2025-04-08
Company comments Product is discontinued as previously reported.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2025-04-08 French Compare
v6 2025-04-08 English Compare
v5 2024-04-05 French Compare
v4 2024-04-05 English Compare
v3 2023-03-10 French Compare
v2 2023-03-10 English Compare
v1 2023-03-10 English Compare

Showing 1 to 7 of 7